PL2563803T3 - Przeciwnowotworowe laktony steroidowe nienasycone w pozycji 7(8) - Google Patents

Przeciwnowotworowe laktony steroidowe nienasycone w pozycji 7(8)

Info

Publication number
PL2563803T3
PL2563803T3 PL11716407T PL11716407T PL2563803T3 PL 2563803 T3 PL2563803 T3 PL 2563803T3 PL 11716407 T PL11716407 T PL 11716407T PL 11716407 T PL11716407 T PL 11716407T PL 2563803 T3 PL2563803 T3 PL 2563803T3
Authority
PL
Poland
Prior art keywords
anticancer
unsaturated
steroidal lactones
lactones
steroidal
Prior art date
Application number
PL11716407T
Other languages
English (en)
Inventor
Rodríguez Rogelio Fernández
Benítez José Fernando Reyes
Solloso Andrés Francesch
Marchante María Del Carmen Cuevas
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44544049&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2563803(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of PL2563803T3 publication Critical patent/PL2563803T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PL11716407T 2010-04-27 2011-04-26 Przeciwnowotworowe laktony steroidowe nienasycone w pozycji 7(8) PL2563803T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10382095 2010-04-27
PCT/EP2011/056566 WO2011134954A1 (en) 2010-04-27 2011-04-26 Anticancer steroidal lactones unsaturated in position 7 (8)
EP11716407.9A EP2563803B1 (en) 2010-04-27 2011-04-26 Anticancer steroidal lactones unsaturated in position 7(8)

Publications (1)

Publication Number Publication Date
PL2563803T3 true PL2563803T3 (pl) 2016-08-31

Family

ID=44544049

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11716407T PL2563803T3 (pl) 2010-04-27 2011-04-26 Przeciwnowotworowe laktony steroidowe nienasycone w pozycji 7(8)

Country Status (29)

Country Link
US (1) US8962602B2 (pl)
EP (1) EP2563803B1 (pl)
JP (1) JP5815675B2 (pl)
KR (1) KR101855453B1 (pl)
CN (1) CN102947322B (pl)
AU (1) AU2011247634B2 (pl)
BR (1) BR112012027393B1 (pl)
CA (1) CA2797468C (pl)
CL (1) CL2012003006A1 (pl)
CY (1) CY1117541T1 (pl)
DK (1) DK2563803T3 (pl)
ES (1) ES2574205T3 (pl)
HK (1) HK1183036A1 (pl)
HR (1) HRP20160523T1 (pl)
HU (1) HUE028751T2 (pl)
IL (1) IL222707B (pl)
ME (1) ME02488B (pl)
MX (1) MX2012012523A (pl)
MY (1) MY162934A (pl)
NZ (1) NZ603261A (pl)
PL (1) PL2563803T3 (pl)
RS (1) RS54780B1 (pl)
RU (1) RU2572595C2 (pl)
SG (2) SG185032A1 (pl)
SI (1) SI2563803T1 (pl)
SM (1) SMT201600139B (pl)
UA (1) UA112746C2 (pl)
WO (1) WO2011134954A1 (pl)
ZA (1) ZA201208092B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011083725A1 (de) 2011-09-29 2013-04-04 Bayer Pharma AG Estra-1,3,5(10),16-tetraen-3-carboxamid-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
EP3125920B1 (en) 2014-04-04 2020-12-23 Del Mar Pharmaceuticals Dianhydrogalactitol, diacetyldianhydrogalactitol or dibromodulcitol to treat non-small-cell carcinoma of the lung and ovarian cancer
CN105017368B (zh) * 2015-06-26 2016-09-28 南通大学 人参二醇衍生物及其制备方法与应用
CN105968167B (zh) * 2016-05-05 2017-10-17 江苏省中医药研究院 环氧蟾毒烯酮的制备方法及其作为抗肿瘤药物的用途
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
IL304892A (en) * 2021-02-02 2023-10-01 Neupharma Inc Certain chemical entities, compositions and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1577633A (en) * 1976-12-17 1980-10-29 Degussa Acyl derivatives of hellebrigenin
JPH04290899A (ja) * 1991-03-18 1992-10-15 Sankyo Co Ltd カルデノライド化合物
JPH05112596A (ja) * 1991-10-20 1993-05-07 Reisa Cho ブフアリンおよびブフアジエノリドを有効成分とす医薬
JP2002536415A (ja) * 1999-02-12 2002-10-29 セルパス インコーポレイテッド 抗腫瘍療法
IL135707A0 (en) 2000-04-17 2001-05-20 Yissum Res Dev Co 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
WO2002014343A1 (en) * 2000-08-17 2002-02-21 Terness, Peter Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents
CA2418458A1 (fr) 2003-02-06 2004-08-06 Neokimia Inc. Synthese totale de 14 beta-fluorosteroides via la reaction de diels-alder transannulaire
GB0509829D0 (en) 2005-05-13 2005-06-22 Guys And St Thomas Nhs Foundat Compound
CN100384830C (zh) * 2006-01-12 2008-04-30 天津药物研究院 环黄芪醇类衍生物以及用途
AU2006343317A1 (en) * 2006-05-09 2007-11-15 University Of Louisville Research Foundation Treating cancer with cardiac glycosides
US20090018088A1 (en) * 2006-10-27 2009-01-15 University Of Louisville Research Foundation Treating cancer with cardiac glycosides

Also Published As

Publication number Publication date
DK2563803T3 (en) 2016-05-30
CA2797468A1 (en) 2011-11-03
EP2563803B1 (en) 2016-03-09
CN102947322B (zh) 2016-09-07
CA2797468C (en) 2018-04-24
JP5815675B2 (ja) 2015-11-17
IL222707A0 (en) 2012-12-31
SG185032A1 (en) 2012-11-29
EP2563803A1 (en) 2013-03-06
RU2572595C2 (ru) 2016-01-20
HUE028751T2 (en) 2017-01-30
CN102947322A (zh) 2013-02-27
MY162934A (en) 2017-07-31
BR112012027393B1 (pt) 2020-12-29
US20130040921A1 (en) 2013-02-14
BR112012027393A2 (pt) 2017-08-08
KR101855453B1 (ko) 2018-06-20
HK1183036A1 (zh) 2013-12-13
IL222707B (en) 2018-06-28
US8962602B2 (en) 2015-02-24
ME02488B (me) 2017-02-20
SG10201503290TA (en) 2015-06-29
SI2563803T1 (sl) 2016-06-30
AU2011247634B2 (en) 2016-07-07
CY1117541T1 (el) 2017-04-26
UA112746C2 (uk) 2016-10-25
KR20130118730A (ko) 2013-10-30
SMT201600139B (it) 2016-07-01
JP2013525403A (ja) 2013-06-20
HRP20160523T1 (hr) 2016-06-03
MX2012012523A (es) 2012-12-17
NZ603261A (en) 2014-12-24
RS54780B1 (sr) 2016-10-31
RU2012150501A (ru) 2014-06-10
ZA201208092B (en) 2014-03-26
WO2011134954A1 (en) 2011-11-03
CL2012003006A1 (es) 2013-10-18
ES2574205T3 (es) 2016-06-15

Similar Documents

Publication Publication Date Title
IL286348A (en) Pharmaceutical preparations that include allopregnanolone
HK1181998A1 (en) Pharmaceutical emulsion compositions comprising progestogen
EP2606072A4 (en) SYNERGISTIC BIOMOLECULAR POLYMER CONJUGATES
IL212805A0 (en) Steroidal compositions
IL218928A0 (en) Orylly administered corticosteroid compositions
LT2616076T (lt) Farmacinės kompozicijos
HK1183036A1 (zh) 位不飽和的抗癌甾體內酯
ZA201300967B (en) Combination anti-cancer therapy
HK1179513A1 (en) Paclitaxel steroidal complex
EP2485721A4 (en) APOGOSSYPOLONE DERIVATIVES AS ANTICANCER AGENTS
SG10201508982TA (en) Pharmaceutical compositions
SI2538955T1 (sl) Farmacevtska ali nutracevtska formulacija
PL2632916T3 (pl) Nowe środki przeciwnowotworowe
EP2565192A4 (en) CANCER AGENT
GB201002318D0 (en) Dietary supplement composition
GB201011390D0 (en) Retaining device for singing balloon and balloon singing incorporating same
PL2637876T3 (pl) Pocztówka
EP2560678A4 (en) PHARMACEUTICAL COMPOSITIONS
ZA201300098B (en) Pharmaceutical composition with enhanced solubility characteristics
HK1200328A1 (zh) 含有孕激素的低油藥用乳液組合物
PL393257A1 (pl) Nowe diestry betuliny i sposób ich otrzymywania
TWM390139U (en) Triggering control part structure improvement in the chiropratic device
GB201006013D0 (en) Tied panel structure
IL226378A0 (en) preparations@rokkhot
GB201002314D0 (en) Dietary supplement composition